// App-Quantinova.ai

4039 : Hemoglobin-A1c level to predict for clinical outcomes in patients with pancreatic cancer.

Researchers

Presenter

  • Katherine Y. Fan

Principal Investigators

  • Aaron Tyler Wild

  • Daniel A. Laheru

  • Ralph H. Hruban

  • Elliot K. Fishman

  • Todd D. Brown

  • Timothy M. Pawlik

  • Christopher Lee Wolfgang

  • Phuoc T. Tran

  • Joseph M. Herman

  • Zheng Su

  • Amy Hacker-Prietz

  • Rachit Kumar

  • Mary Hodgin

  • Charles C. Hsu

  • Dung T. Le

  • Ana De Jesus-Acosta

  • Luis A. Diaz

Medical Centers

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

  • Johns Hopkins University, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD

  • Stanford Univ, Palo Alto, CA

  • University of California, San Francisco, San Francisco, CA

  • Johns Hopkins University School of Medicine, Baltimore, MD

  • Johns Hopkins University, Baltimore, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • Hemoglobin A1c

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved